Celsion Corporation is a fully integrated biopharmaceutical company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies. Our lead product candidate is ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in a phase 3 trial combined with RFA for the treatment of hepatocellular carcinoma. Second in our pipeline is GEN-1, a DNA-mediated immunotherapy for the localized treatment of ovarian cancer.
Celsion has 3 platform technologies providing the basis for the development of a range of therapeutics for difficult-to-treat forms of cancers. With these technologies we are working to develop and commercialize more efficient, effective, and targeted oncology therapies, maximizing efficacy while minimizing side effects common to cancer treatments.
Celsion’s mission is to transform the landscape of cancer treatment with novel targeting technologies. Our ultimate goal is to cure challenging cancers, transitioning from the passion of what is possible to the science of what is proven.
Our platform technologies
We currently have three platform technologies providing the basis for the future development of a range of therapeutics for difficult-to-treat forms of cancer.
Our lead product candidates
Our lead product candidate is ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, currently being evaluated in a phase 3 clinical trial for the treatment of primary liver cancer (OPTIMA Study). Second in our pipeline is GEN-1, a DNA-mediated immunotherapy for the localized treatment of ovarian and brain cancers.
ThermoDox has also shown great promise in recurrent chest wall (RCW) breast cancer patients. The Company intends to devote future resources to further exploring the application of ThermoDox in this indication.
Celsion is headquartered in Lawrenceville, New Jersey. Our discovery and preclinical operations, as well as our analytical services and laboratory functions, are based in Huntsville, Alabama.
ThermoDox is a registered trademark of Celsion Corporation.
TheraPlas and TheraSilence are trademarks of Celsion Corporation.